Видео

#iDR24 was co-organised by REMEDi4ALL, Beacon and MeRIT on 6-7 March 2024 in Barcelona. The conference titled "Bridging Boundaries: Innovating, Connecting & Reshaping Drug Repurposing" gathered key opinion leaders from both the research and patient communities, funders, regulators and representatives from the private sector to collectively advance innovative drug repurposing in Europe and beyon...

#iDR24 was co-organised by REMEDi4ALL, Beacon and MeRIT on 6-7 March 2024 in Barcelona. The conference titled "Bridging Boundaries: Innovating, Connecting & Reshaping Drug Repurposing" gathered key opinion leaders from both the research and patient communities, funders, regulators and representatives from the private sector to collectively advance innovative drug repurposing in Europe and beyon...

#iDR24 was co-organised by REMEDi4ALL, Beacon and MeRIT on 6-7 March 2024 in Barcelona. The conference titled "Bridging Boundaries: Innovating, Connecting & Reshaping Drug Repurposing" gathered key opinion leaders from both the research and patient communities, funders, regulators and representatives from the private sector to collectively advance innovative drug repurposing in Europe and beyon...

Visit our website and join the conversation about medicines repurposing on social media. - Website: remedi4all.org/ - Twitter REMEDi4ALL/ - LinkedIn www.linkedin.com/company/reme... - Facebook: REMEDi4ALL - RUclips: ruclips.net/channel/UCTLB... #R4ALL #eufunded #HorizonEU #DrugRepurposing #MedicinesRepurposing #PatientCentric #PatientBenefit #PatientInvolvement #TranslationalR...

Is drug repurposing, an attractive strategy in pancreatic cancer treatment? Hear from experts in the video. The REMEDi4ALL project has received funding from the European Union’s Horizon Europe Research & Innovation programme under grant agreement No 101057442. Visit our website for more information at remedi4all.org

Is drug repurposing an attractive strategy for pancreatic cancer treatment? The REMEDi4ALL project has received funding from the European Union’s Horizon Europe Research & Innovation programme under grant agreement No 101057442. Visit our website for more information at remedi4all.org

Martin de Kort (EATRIS) invites you to join the International Drug Repurposing Conference 2024 (#iDR24): Bridging Boundaries for Innovative Drug Repurposing. Co-organised by REMEDi4ALL Consortium, Beacon for Rare Diseases, and MeRIT, the conference showcases how patient communities, researchers, industry, and health authorities can benefit from cutting-edge drug repurposing. 🔗 remedi4all.org/in...

Martin de Kort (EATRIS) invites you to join the International Drug Repurposing Conference 2024 (#iDR24): Bridging Boundaries for Innovative Drug Repurposing. Co-organised by REMEDi4ALL Consortium, Beacon for Rare Diseases, and MeRIT, the conference showcases how patient communities, researchers, industry, and health authorities can benefit from cutting-edge drug repurposing. 🔗 remedi4all.org/in...

Heleen Van der Meer (ZonMw) encourages Funders to join the International Drug Repurposing Conference 2024 (#iDR24): Bridging Boundaries for Innovative Drug Repurposing. Co-organised by REMEDi4ALL Consortium, Beacon for Rare Diseases, and MeRIT, the conference showcases how patient communities, researchers, industry, and health authorities can benefit from cutting-edge drug repurposing. 🔗 remedi...

In the context of Rare Diseases Day, Virginie Hivert, EURORDIS Therapeutic Development Director, talks about the collaborative aspect of bringing together a development team of researchers, patients and decision makers to advance medicine repurposing. Visit our website and join the conversation about medicines repurposing on social media. - Website: remedi4all.org/ - Twitter REMEDi4...

Nick Sireau (CEO & Chair of Trustees, AKU Society) talks about what REMEDi4ALL is doing to fill the gap in rare diseases. Visit our website and join the conversation about medicines repurposing on social media. - Website: remedi4all.org/ - Twitter REMEDi4ALL/ - LinkedIn www.linkedin.com/company/remedi4all/ - Facebook: REMEDi4ALL - RUclips: ruclips.net/channel/UCTLBcp0p_roMGrh_...

Lars Schlotawa (Pediatrician/Consultant for Paedriatics University Medical Center Goettingen) explains how REMEDi4ALL will support researchers working in rare diseases. Visit our website and join the conversation about medicines repurposing on social media. - Website: remedi4all.org/ - Twitter REMEDi4ALL/ - LinkedIn www.linkedin.com/company/reme... - Facebook: REMEDi4ALL - RUc...

Nick Sireau (CEO & Chair of Trustees, AKU Society) talks about how DrugRepurposing changed his children's condition. Visit our website and join the conversation about medicines repurposing on social media. - Website: remedi4all.org/ - Twitter REMEDi4ALL/ - LinkedIn www.linkedin.com/company/remedi4all/ - Facebook: REMEDi4ALL - RUclips: ruclips.net/channel/UCTLBcp0p_roMGrh_Eeo3b...

Virginie Hivert, Therapeutic Development Director at EURORDIS, calls for researchers in the rare diseases field to discover what REMEDi4ALL can offer. Visit our website and join the conversation about medicines repurposing on social media. - Website: remedi4all.org/ - Twitter REMEDi4ALL/ - LinkedIn www.linkedin.com/company/remedi4all/ - Facebook: REMEDi4ALL - RUclips: ruclips....

Rick Thompson (BEACON) on what REMEDi4ALL can do for the rare disease community

Lars Schlotawa explains how medicine repurposing can bring rare diseases closer to a therapy

Rick Thompson (BEACON) on the impact of drug repurposing for the rare disease community

Anton Ussi, EATRIS's Operations & Finance Director & REMEDi4All's Project Coordinator.

Pancreatic Cancer Day

REMEDi4ALL - Kick-off Meeting 2022